The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and Resistance
Open accessAbstract
Hepatic stellate cells are similar to tissue pericytes and have been shown to be contractile. In this study, we examined the effects of known mediators of stellate cell contraction on portal pressure in rat livers after carbon tetrachloride induced injury (including cirrhosis) and investigated the contractility of stellate cells as a function of liver injury. Sarafotoxin S6C, an endothelin B (ETB) receptor agonist, had minor effects on portal pressure when perfused into normal livers at concentrations known to elicit stellate cell contraction (2 nmol/L). In contrast, both endothelin–1 (2 nmol/L) and angiotensin II (8.6 nmol/L) caused a rapid and pronounced rise in portal pressure. The effects of sarafotoxin S6C (a potent stellate cell contractile agonist) on portal pressure were greater in cirrhotic than normal liver, whereas those of angiotensin II were unchanged after liver injury. Endothelin–1 and sarafotoxin S6C induced contractility of stellate cells increased in proportion to the degree of liver injury. Contractility was greatest for stellate cells isolated from cirrhotic livers, a population of cells that displayed the most activated phenotype, as measured by immunoblot of smooth muscle alpha actin. Autoradiography of cirrhotic livers after perfusion with 125I–endothelin–1 revealed binding to cells in both sinusoidal spaces and collagenous fibrotic bands, consistent with known locations of stellate cells. Finally, the mixed endothelin–A (ETA) and ETB receptor antagonist, bosentan, reduced portal pressure in portal hypertensive animals, consistent with its inhibitory effect on stellate cell contraction. We conclude that stellate cell contractility increases with progressive liver injury and is proportional to the degree of stellate cell activation, becoming most prominent in the cirrhotic liver. Endothelin–stimulated contraction of stellate cells in cirrhotic liver may contribute to increased intrahepatic resistance and portal pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High Yield Micronodular Cirrhosis in the Rat
Proctor, E., & Chatamra, K. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80126-1 · Cited by 281
A dynamic and static study of hepatic arterioles and hepatic sphincters
McCuskey, R. S. (1966) · American Journal of Anatomy · doi:10.1002/aja.1001190307 · Cited by 233
Endothelin, a potent peptide agonist in the liver.
Gandhi, C. R., Stephenson, K. E., & Olson, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38180-8 · Cited by 160
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
Lüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Vollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
Bataller, R., Ginès, P., Nicolás, J. M., Görbig, M. N., Garcia–Ramallo, E., Gasull, X., Bosch, J., Arroyo, V., & Rodés, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70368-4 · Cited by 490
Complications of cirrhosis. I. Portal hypertension
Bosch, J., & García-Pagán, J. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80422-5 · Cited by 490
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
Wiest, R., & Groszmann, R. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31432 · Cited by 471
Arroyo, V., Angeli, P., Moreau, R., Jalan, R., Clària, J., Trebicka, J., Fernández, J., Gustot, T., Caraceni, P., & Bernardi, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.048 · Cited by 458
Role of liver sinusoidal endothelial cells in liver diseases
Gracia-Sancho, J., Caparrós, E., Fernández-Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 410
Rockey, D. C., & Chung, J. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70487-1 · Cited by 409
Self-citationYOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H. (2001) · Hepatology · doi:10.1053/jhep.20001.28231 · Cited by 397
Gupta, T. K., Toruner, M., Chung, M. K., & Groszmann, R. J. (1998) · Hepatology · doi:10.1002/hep.510280405 · Cited by 385
Experimental models of liver fibrosis
Crespo Yanguas, S., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., Leclercq, I., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1543-4 · Cited by 350
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Pathophysiology of Portal Hypertension
Iwakiri, Y. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.12.001 · Cited by 337
Rockey, D. (1997) · Hepatology · doi:10.1002/hep.510250102 · Cited by 336
Self-citationThe management of portal hypertension: Rational basis, available treatments and future options
Bosch, J., Berzigotti, A., Garcia-Pagan, J. C., & Abraldes, J. G. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.021 · Cited by 319
Zafra, C., Abraldes, J. G., Turnes, J., Berzigotti, A., Fernández, M., Garcı́a-Pagán, J. C., Rodés, J., & Bosch, J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.007 · Cited by 297
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension
Reynaert, H., Thompson, M. G., Thomas, T., & Geerts, A. (2002) · Gut · doi:10.1136/gut.50.4.571 · Cited by 289
Bacterial infection in the pathogenesis of variceal bleeding
Goulis, J., Patch, D., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06020-6 · Cited by 286
Gupta, T. K., Toruner, M., & Groszmann, R. J. (1998) · Digestion · doi:10.1159/000007500 · Cited by 260
Bellot, P., Francés, R., & Such, J. (2013) · Liver International · doi:10.1111/liv.12021 · Cited by 254
Akkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
González-Abraldes, J., Albillos, A., Bañares, R., Del Arbol, L. R., Moitinho, E., Rodríguez, C., González, M., Escorsell, A., García-Pagán, J. C., & Bosch, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26288 · Cited by 165
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
Alsamman, S., Christenson, S. A., Yu, A., Ayad, N. M. E., Mooring, M. S., Segal, J. M., Hu, J. K.-H., Schaub, J. R., Ho, S. S., Rao, V., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8798 · Cited by 122
Hepatic Fibrosis, Stellate Cells, and Portal Hypertension
Rockey, D. C. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.017 · Cited by 112
Self-citationAngiocrine signaling in sinusoidal homeostasis and liver diseases
Gao, J., Lan, T., Kostallari, E., Guo, Y., Lai, E., Guillot, A., Ding, B., Tacke, F., Tang, C., & Shah, V. H. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.014 · Cited by 90
Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand
Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., & Li, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013955 · Cited by 66
Koda, M., Bauer, M., Krebs, A., Hahn, E. G., Schuppan, D., & Murawaki, Y. (2006) · Comparative Hepatology · doi:10.1186/1476-5926-5-5 · Cited by 17
Metadata
- Authors
- Rockey, D. C., & Weisiger, R. A.
- Venue
- Hepatology
- Published
- 1996-07
- Volume
- 24
- Issue
- 1
- Pages
- 233-240
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1977983569
- Cited by
- 385
- References
- 3
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.